JASPER THERAPEUTICS, INC. Non Peo Neo Avg Comp Actually Paid Amt
JASPER THERAPEUTICS, INC. (JSPR) reported Non Peo Neo Avg Comp Actually Paid Amt of -$2.08 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-06-15.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:NonPeoNeoAvgCompActuallyPaidAmt · last filed 2026-06-15
| Period end | Non Peo Neo Avg Comp Actually Paid Amt 12 month |
|---|---|
| 2025-12-31 | -$2.08M DEF 14A · filed 2026-06-15 |
| 2024-12-31 | $2.49M DEF 14A · filed 2026-06-15 |
| 2023-12-31 | $762.13K DEF 14A · filed 2026-06-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |